Development of printable
pharmaceutical formulations

Choosing the right MB Therapeutics technology: Our rapid screening approach uses techniques to characterize parameters such as particle size, material rheology, solubility, polymorphism, or physicochemical stability of active ingredients. This allows us to identify the appropriate 3D printing technology.

Our experience is built upon years of work integrating the development of formulations suitable for 3D printing technologies. Compatibility studies with excipients are carried out to support prototype formulation selection.

In order to find the right parameters for producing the best next-generation medications, we employ the Quality by Design approach and use Design of Experiments (DoE) to determine the optimal way to print your medications.

Using MB Therapeutics 3D printing technology, we can provide you with technical batches to define the best approach for conducting clinical trials.